TWD 45.5
(0.22%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 656.05 Million TWD | -6.74% |
2022 | 703.49 Million TWD | -24.08% |
2021 | 926.58 Million TWD | 11.17% |
2020 | 833.48 Million TWD | -0.15% |
2019 | 834.74 Million TWD | 40.97% |
2018 | 592.16 Million TWD | 19.72% |
2017 | 494.62 Million TWD | 16.73% |
2016 | 423.72 Million TWD | 21.66% |
2015 | 348.28 Million TWD | 10.07% |
2014 | 316.42 Million TWD | -6.99% |
2013 | 340.21 Million TWD | 11.67% |
2012 | 304.66 Million TWD | 0.18% |
2011 | 304.12 Million TWD | 24.61% |
2010 | 244.05 Million TWD | -3.0% |
2009 | 251.59 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 769.2 Million TWD | 33.69% |
2024 Q1 | 575.34 Million TWD | -12.3% |
2023 Q1 | 559.02 Million TWD | -20.54% |
2023 Q4 | 656.05 Million TWD | -5.74% |
2023 Q3 | 695.99 Million TWD | -11.55% |
2023 Q2 | 786.89 Million TWD | 40.76% |
2023 FY | 656.05 Million TWD | -6.74% |
2022 Q2 | 852.94 Million TWD | 6.73% |
2022 Q1 | 799.14 Million TWD | -13.75% |
2022 FY | 703.49 Million TWD | -24.08% |
2022 Q4 | 703.49 Million TWD | -6.14% |
2022 Q3 | 749.5 Million TWD | -12.13% |
2021 Q4 | 926.58 Million TWD | 8.6% |
2021 Q3 | 853.21 Million TWD | -2.37% |
2021 Q2 | 873.89 Million TWD | 7.04% |
2021 Q1 | 816.44 Million TWD | -2.04% |
2021 FY | 926.58 Million TWD | 11.17% |
2020 Q4 | 833.48 Million TWD | -4.98% |
2020 Q1 | 749.87 Million TWD | -10.17% |
2020 Q3 | 877.21 Million TWD | -1.87% |
2020 FY | 833.48 Million TWD | -0.15% |
2020 Q2 | 893.89 Million TWD | 19.21% |
2019 Q4 | 834.74 Million TWD | 11.9% |
2019 FY | 834.74 Million TWD | 40.97% |
2019 Q3 | 745.94 Million TWD | -12.02% |
2019 Q2 | 847.87 Million TWD | 33.69% |
2019 Q1 | 634.18 Million TWD | 7.1% |
2018 Q2 | 629.01 Million TWD | 65.87% |
2018 FY | 592.16 Million TWD | 19.72% |
2018 Q1 | 379.21 Million TWD | -23.33% |
2018 Q4 | 592.16 Million TWD | -15.44% |
2018 Q3 | 700.31 Million TWD | 11.33% |
2017 Q3 | 448.62 Million TWD | -9.34% |
2017 FY | 494.62 Million TWD | 16.73% |
2017 Q1 | 310.94 Million TWD | -26.62% |
2017 Q2 | 494.81 Million TWD | 59.14% |
2017 Q4 | 494.62 Million TWD | 10.25% |
2016 Q3 | 385.92 Million TWD | -17.97% |
2016 Q4 | 423.72 Million TWD | 9.79% |
2016 FY | 423.72 Million TWD | 21.66% |
2016 Q1 | 310.8 Million TWD | -10.76% |
2016 Q2 | 470.45 Million TWD | 51.36% |
2015 Q2 | 430.28 Million TWD | 52.6% |
2015 Q1 | 281.97 Million TWD | -10.89% |
2015 FY | 348.28 Million TWD | 10.07% |
2015 Q3 | 311.46 Million TWD | -27.61% |
2015 Q4 | 348.28 Million TWD | 11.82% |
2014 Q2 | 411.71 Million TWD | 39.94% |
2014 FY | 316.42 Million TWD | -6.99% |
2014 Q4 | 316.42 Million TWD | 8.32% |
2014 Q3 | 292.11 Million TWD | -29.05% |
2014 Q1 | 294.21 Million TWD | -13.52% |
2013 Q1 | - TWD | -100.0% |
2013 Q2 | 385.98 Million TWD | 0.0% |
2013 Q3 | 304.96 Million TWD | -20.99% |
2013 Q4 | 340.21 Million TWD | 11.56% |
2013 FY | 340.21 Million TWD | 11.67% |
2012 FY | 304.66 Million TWD | 0.18% |
2012 Q2 | 417.3 Million TWD | 0.0% |
2012 Q4 | 304.66 Million TWD | 0.0% |
2011 Q2 | 292.66 Million TWD | 0.0% |
2011 FY | 304.12 Million TWD | 24.61% |
2011 Q4 | 304.12 Million TWD | 0.0% |
2010 FY | 244.05 Million TWD | -3.0% |
2010 Q4 | 244.05 Million TWD | 0.0% |
2009 FY | 251.59 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Farcent Enterprise Co.,Ltd | 591.03 Million TWD | -11.002% |
Mao Bao Inc. | 175.04 Million TWD | -274.798% |
Taiyen Biotech Co., Ltd. | 1.77 Billion TWD | 62.954% |
Chlitina Holding Limited | 3.75 Billion TWD | 82.534% |
Jourdeness Group Limited | 5.77 Billion TWD | 88.645% |
Nan Liu Enterprise Co., Ltd. | 6.88 Billion TWD | 90.467% |
Luo Lih-Fen Holding Co., Ltd. | 493.87 Million TWD | -32.838% |
San Neng Group Holdings Co., Ltd. | 488.94 Million TWD | -34.177% |
Yuen Foong Yu Consumer Products Co., Ltd. | 3.21 Billion TWD | 79.599% |
KNH Enterprise Co., Ltd. | 4.94 Billion TWD | 86.738% |